$1.50
-0.01-0.66%
Last update: Nov 9, 9:10 AM
Equillium Inc
EQNASDAQ
The average analyst price target for Equillium is $8.71, 471.1% above the current price. Of 7 analysts, 6 rate it Buy and 1 Hold. Targets range from $5 to $20. The latest change came on Oct 12, 2026, when Leerink Partners assumed coverage of Equillium with an Outperform rating and a $6 price target.
Price Target Range — 8 Quarters
Analyst Consensus — 7 Analysts
Rating Trend — Last 9 Months
